ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679509; 2) Community: the network communities that were significantly associated with the response to NSC 679509; 3) Molecule: the relationships between components within communities and NSC 679509; 4) MDR: the compounds that were significantly associated with the NSC 679509.

NSC Compound Enrichment Correlation
NSC 83492 Null 0.0312262198176281 -0.13842237
NSC 113951 6-Bromotoyocamycin 0.0312262198176283 0.026897793
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0312262198176283 0.12302436
NSC 333571 Benzoic acid, 3,4,5-trihydroxy-, phenyl ester 0.0312262198176283 0.35914514
NSC 606498 Camptothecin Derivative 0.0312262198176283 0.22424361
NSC 639734 Null 0.0312262198176283 0.095963923
NSC 651853 Null 0.0312262198176283 0.10660114
NSC 653846 Benzoic acid, 2-hydroxy-, 2-[(3,4-dimethoxyphenyl)(cyano) methyl]hyrazide 0.0312262198176283 0.26855625
NSC 666220 Null 0.0312262198176283 0.13758754
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.0312262198176283 -0.3109532
Total:47  Current:27    [First] [Prev] [Next] [Last]